Why BGPT?
logo

Assess an author's data and outputs

See the raw experimental evidence behind an author's publications and reproducibility signals.







Press Enter ↵ to solve



    Fuel Your Discoveries




     Quick Explanation


    BGPT evidence-limited critique
    Based on the provided raw-paper extracts only (and without verifying full authorship/author-order or the author’s role in each item), Arturo Reyes-Sandoval’s apparent research output clusters around viral vector immunology and arbovirus/malaria vaccine-relevant assays, including simian adenoviral vaccine immunogenicity/protective readouts in mice [sterile protection, effector-memory CD8 bias, multifunctionality] and adenoviral-vectored alphavirus candidates with homologous protection plus partial heterologous effects in IFNAR−/− challenge models .
    However, because the author’s specific contributions are not verified in the provided excerpt data, the scientific-strength score is necessarily conservative.



     Long Explanation


    Author Review (BGPT): Arturo Reyes-Sandoval
    Epistemic humility: The dataset you provided contains paper titles and extracted content, but it does not explicitly verify that Arturo Reyes-Sandoval is an author on those specific works, nor does it provide author-order / contribution statements. Therefore, I can evaluate only the scientific characteristics of the provided papers (models, assays, strength of evidence, limitations), and I will not over-attribute findings to the individual.
    1) Visuals from the provided raw extracts
    Two provided extracts contain numeric immune-readout/protection values that can be visualized without inventing missing data.
    Visual data provenance:
    • Protection day14/day60 values are taken directly from the provided extract on simian adenoviral vectors against Plasmodium berghei .
    • E2 IgG log10 values are taken directly from the provided adenoviral-vectored Mayaro/Chikungunya vaccine extract .
    2) Scientific-strength assessment (evidence-weighted, skeptical)
    A. What the provided evidence suggests (known vs inferred)
    • The provided adenoviral-vectored alphavirus extract reports homologous protection after vaccination in a highly susceptible IFNAR−/− model (A129 mice), alongside partial heterologous cross-protection, with E2-directed antibodies detected but cross-neutralizing titers reported as low—implying non-neutralizing and/or Fc-mediated mechanisms may contribute (as stated in the extract, but not fully dissected there) .
    • The malaria adenoviral-vector extract reports a link between effector-memory biased CD8+ T cells, multifunctional cytokine production, and high early sterile protection, including an explicit pre-existing AdH5 immunity scenario to address a key translation barrier for human adenovirus immunity .
    B. Evidence strength and key methodological features (from extracts)
    • In vivo challenge models: The extracts include lethal or stringent challenge endpoints (A129 mouse model for alphavirus; liver-stage Plasmodium berghei challenge for malaria), which strengthens causal inference compared with purely in vitro immunogenicity studies .
    • Correlates/assays: The malaria extract reports immune phenotype mapping (e.g., memory phenotype markers) and multifunctionality analyses, plus quantification of sterile protection across time .
    • Cross-reactivity vs cross-neutralization: The alphavirus extract explicitly notes that cross-protection can occur even when cross-neutralization titers are low, which is biologically plausible and also a warning against over-relying on neutralization alone .
    C. Blind spots / limitations explicitly noted in the extracts
    • The malaria vector extract highlights species-model constraints: protection is shown in Pb berghei with rodent vectors/immune systems, and durability is limited in the reported time window (day 60) .
    • The alphavirus vector extract reports limitations consistent with translation risk: IFNAR−/− mice are highly susceptible; modest group sizes are noted; and mechanistic dissection of Fc/non-neutralizing pathways is not fully explicit in the extract .
    • Authorship/role uncertainty: Without a verified mapping from the individual to the provided papers, attribution of “scientific rigor/novelty” to Arturo Reyes-Sandoval is underdetermined by the provided dataset.
    D. Citation metrics (as provided) and what they can/cannot show
    The provided author metrics indicate h-index = 1, total citations = 8, and paper count = 8. In isolation, this is consistent with an early-career profile or with limited indexing/coverage, and it is not itself a direct measure of experimental quality. Additionally, an attempt to retrieve OpenAlex data timed out, so I cannot corroborate with OpenAlex in this run.
    3) Reviewer judgments (strict, conservative)
    • Strength signal: The provided extracts show an emphasis on vaccine immunology with in vivo challenge endpoints and time-dependent protection (e.g., day 14 vs day 60 sterile protection) .
    • Weakness signal: Durable, mechanism-resolving validation appears limited in the extracts (e.g., no long-term durability beyond the tested window; limited explicit Fc mechanism dissection in the cross-protection study extract) .
    • Attribution uncertainty: Because the provided data do not confirm the author’s exact contributions to these specific works, I do not treat these evidences as direct proof of the author’s personal experimental execution or conceptual leadership.
    4) Targeted next steps (BGPT query shortcuts)
    These are designed to make the next review step verifiable and less assumption-driven.


    Feedback:    

    Updated: April 02, 2026

     BGPT Author Review


    Scientific Quality

    40%

    Score is conservative because the provided dataset does not verify Arturo Reyes-Sandoval’s authorship role on the listed papers, and only two detailed extracts were provided. The extracts themselves show reasonably robust immunology with in vivo challenge endpoints and some durability/timing (e.g., day 14 vs day 60), but also highlight translation limits (rodent models, IFNAR−/− susceptibility) and incomplete mechanistic dissection in the cross-protection extract. Citation metrics provided (h-index 1; citations 8) suggest limited measurable impact so far, which weakly correlates with but does not establish low quality.


    Communication Quality

    60%

    Cannot reliably judge personal communication quality because the dataset provides titles/excerpts but not the author’s narrative writing, figures, or contribution-specific drafts. The scientific extracts summarize methods and limitations in a structured way, which is a mild positive signal, but author-specific communication remains unassessable here.


    Author Novelty

    50%

    Within the provided extracts, the science is conceptually aligned with established areas (adenoviral vectored vaccines, cross-protection, memory-biased CD8 responses). Novelty appears moderate (e.g., addressing pre-existing AdH5 immunity and reporting cross-protection despite low cross-neutralization), but the provided information does not establish how novel the author’s specific contribution was relative to the field.


    Scientific Rigor

    50%

    Rigor is moderate based on the extract features: challenge endpoints, immune phenotyping, and some statistical framing are described. However, key rigor signals are missing from the provided excerpts (randomization/blinding detail beyond what is summarized; no public accession numbers mentioned in the malaria extract; limited mechanistic dissection in the alphavirus cross-protection extract). Also, insufficient evidence links rigor to the individual author.

     Hypothesis Graveyard


    A hypothesis that cross-protection in alphavirus vaccination is primarily driven by heterologous neutralizing antibodies is less favored here because the extract describes low cross-neutralization titers despite protective/attenuated outcomes .


    A hypothesis that effector-memory phenotype alone guarantees long-term sterile protection is weakened by the malaria extract’s observed waning by day 60 even for top vectors, implying additional constraints on maintenance signals beyond phenotype snapshot ."

     Science Art


    Author Review: Arturo Reyes-Sandoval Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT






     Trending